Orchard Therapeutics plc Overview

Orchard Therapeutics plc Cost of Revenue

Cost of Revenue analysis for ORTX.

Quarterly Cost of Revenue

$1.75M

↑ 6.08% YoY

As of Sep 30, 2023

Annual Cost of Revenue (TTM)

$2.40M

↓ 44.77% YoY

Trailing 12 months ending Sep 30, 2023

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin